Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | 13.7 % | 47.03 % |
|
5yr average Equity Multiplier
|
1.99 | 1.24 | -2.46 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 0.36 | 0.6 |
|
5yr Avg Net Profit Margin
|
-0.06 % | 71.53 % | -30.66 % |
|
Price to Book
|
1.26 | 1.95 | 0.0 |
|
P/E
|
0.0 | 38.72 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | 68.18 Days | 97.28 Days |
|
Inventory Days
|
64.96 Days | 62.21 Days | 165.43 Days |
|
Days Receivable
|
72.97 Days | 10.88 Days | 69.98 Days |
|
Days Payable
|
84.21 Days | 199.95 Days | 260.51 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | 815.2 | -1.37 |
|
5yr Avg ROCE
|
5.35 % | 19.97 % | -19.87 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | -101.39 % | -6.94 % |
|
5 yr average Debt to Equity
|
0.49 | 0.0 | -3.0 |
|
5yr CAGR Net Profit
|
n/a | 0.0 | -15.97 % |
|
5yr Average Return on Assets
|
0.6 % | 10.86 % | -18.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 59.53 % | 34.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 3.22 % | -0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|